In neuroblastoma cells (IMR-32), Aβ treatment downregulated PSA-NCAM biosynthetic enzymes, ST8Sia4 and UDP-E, to downregulate PSA-NCAM expression. Here, NCAM1 is linked to neuroblastoma.